Aclarion adds NYU Langone Health as enrolling site for CLARITY trial of Nociscan

Aclarion says NYU Langone Health has been added as a new enrolling site for its ongoing CLARITY randomized trial of Nociscan in spine surgery; outcomes are to be assessed at 12 months.